We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
11 Aug 2021 - 15 Aug 2021
Virtual Venue
16 Aug 2021 - 26 Aug 2021
Virtual Venue

AI Suite Detects Most Common Chest X-Ray Findings

By MedImaging International staff writers
Posted on 15 Mar 2021
Print article
Image: Insight CXR detects abnormalities on a chest X-ray image (Photo courtesy of Lunit)
Image: Insight CXR detects abnormalities on a chest X-ray image (Photo courtesy of Lunit)
A new collaboration between Royal Philips (Amsterdam, The Netherlands) and Lunit (Seoul, South Korea) will make Lunit's AI software, the Insight CXR chest detection suite accessible to users of Philips' diagnostic X-ray solutions. CXR detects ten of the most common findings in a chest X-ray, incluindg small and subtle pulmonary nodules overlapped in the hilar shadow, ribs, heart, and diaphragm, enabling radiologists to reduce overlooked lung cancer cases, especially during regular check-ups.

Lunit Insight CXR is designed to instantly analyze of chest X-ray images by mapping radiological findings and displaying a scored calculation of actual existence. The algorithm shows a 97-99% accuracy rate in the detection of lung nodules, calcifications, consolidation, fibrosis, pneumothorax, pneumoperitoneum, cardiomegaly, pleural effusion, mediastinal widening, atelectasis, and tuberculosis. Data on the detected lesions is presented in the form of heatmaps and/or contour maps, with an abnormality score reflecting the AI’s calculation of the actual presence of the detected lesion.

“Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact,” said Daan van Manen, general manager for diagnostic X-ray at Philips. “Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of smart workflow features in the Philips radiography unified user interface (Eleva), across our digital radiography systems that enables a smooth and efficient, patient-focused workflow.”

“By partnering with Philips, one of the biggest medical device companies globally, our AI will be available to its significant global installed base. With the start of this partnership, we look forward to further expanding our collaboration to make data-driven medicine the new standard of care,” said Brandon Suh, CEO of Lunit. “Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI.”

Related Links:
Royal Philips
Lunit



Print article
Radcal
CIRS

Channels

Industry News

view channel
Illustration

Global AI in Medical Diagnostics Market Projected to Reach USD 3.87 Billion by 2025

The global AI in medical diagnostics market is projected to grow at a CAGR of 50.2% from USD 505 million in 2020 to USD 3.87 billion by 2025, driven primarily by government initiatives to increase adoption... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.